1. Socioeconomic status and breast cancer treatment

   • Marie S. Dreyer
   • Ann B. Nattinger
   • Liliana E. Pezzin

   Review 07 September 2017 Pages: 1 - 8

2. Molecular profile of atypical hyperplasia of the breast

   • David N. Danforth

   Review Open access 14 September 2017 Pages: 9 - 29

   

3. Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis

   • Alberto Gallardo
   • Barbara Garcia-Valdecasas
   • Enrique Lerma

   Preclinical study 01 September 2017 Pages: 31 - 37

   

4. Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer

   • Mariko Kochi
   • Takayuki Iwamoto
   • Toshiyoshi Fujiwara

   Preclinical study 13 September 2017 Pages: 39 - 47

   

5. Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing

   • Nanae Masunaga
   • Naofumi Kagara
   • Shinzaburo Noguchi

   Preclinical study 13 September 2017 Pages: 49 - 58

   

6. Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials

   • Marion T. van Mackelenbergh
   • Carsten Denkert
   • Sibylle Loibl

   Clinical trial 05 September 2017 Pages: 59 - 71

   

7. An observational study investigating failure of primary endocrine therapy for operable breast cancer in the elderly

   • Robert Thomas
   • Rachel Rowell
   • Henry Cain

   Clinical trial 06 September 2017 Pages: 73 - 80

   

8. Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis

   • Naoki Niikura
   • Akihiko Shimomura
   • Hhiroji Iwata

   Clinical trial 11 September 2017 Pages: 81 - 87

   

9. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer

   • Roberto A. Leon-Ferre
   • Mei-Yin Polley
   • Matthew P. Goetz

   Clinical trial 14 September 2017 Pages: 89 - 99

   

10. Characteristics and prognosis of breast cancer after liver or kidney transplantation

    • I-Ji Jeong
    • Sung-Gyu Lee
    • Hee Jeong Kim

    Clinical trial 15 September 2017 Pages: 101 - 106

    

11. Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008

    • Roisin M. Connolly
    • Mary Jo Fackler
    • Saraswati Sukumar

    Clinical trial 16 September 2017 Pages: 107 - 116

    

12. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy

    • Brooke A. Rice
    • Elizabeth S. Ver Hoeve
    • Michelle E. Melisko

    Clinical trial 18 September 2017 Pages: 117 - 122

13. Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial

    • G. Viale
    • F. A. de Snoo
    • for the MINDACT investigators

    Clinical trial 19 September 2017 Pages: 123 - 131

    

14. Obesity, physical activity, and breast cancer survival among older breast cancer survivors in the Cancer Prevention Study-II Nutrition Cohort

    • Maret L. Maliniak
    • Alpa V. Patel
    • Mia M. Gaudet

    Epidemiology 31 August 2017 Pages: 133 - 145

    

15. Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosis

    • N. C. Verheuvel
    • A. C. Voogd
    • R. M. H. Roumen

    Epidemiology Open access 31 August 2017 Pages: 147 - 156

    

16. Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life

    • Rola Hamood
    • Hatem Hamood
    • Lital Keinan-Boker

    Epidemiology 31 August 2017 Pages: 157 - 169

    

17. Healthy lifestyle impact on breast cancer-specific and all-cause mortality

    • Adaline E. Heitz
    • Richard N. Baumgartner
    • Stephanie D. Boone

    Epidemiology 31 August 2017 Pages: 171 - 181

    

18. Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes

    • Ebtihag O. Alenzi
    • S. Suresh Madhavan
    • Xi Tan

    Epidemiology 02 September 2017 Pages: 183 - 193

    

19. Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs

    • Anna N. A. Tosteson
    • Qian Yang
    • Donald L. Weaver

    Epidemiology 06 September 2017 Pages: 195 - 203

    

20. Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients

    • M. L. Gregorowitsch
    • H. J. G. D. van den Bongard
    • H. M. Verkooijen

    Epidemiology Open access 11 September 2017 Pages: 205 - 213

    

21. Healthcare utilization, Medicare spending, and sources of patient distress identified during implementation of a lay navigation program for older patients with breast cancer

    • Gabrielle B. Rocque
    • Courtney P. Williams
    • Elizabeth A. Kvale

    Epidemiology 12 September 2017 Pages: 215 - 223

    

22. Take care of your neighborhood

    • Elmer E. Huerta
    • Patricia Weeks-Coulthurst
    • Sandra M. Swain

    Epidemiology 12 September 2017 Pages: 225 - 234

    

23. Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopausal status or something else?

    • Kirsten A. Nyrop
    • Allison M. Deal
    • Shlomit S. Shachar

    Epidemiology 14 September 2017 Pages: 235 - 248

    

24. Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients

    • Sara Ruiz-Pinto
    • Guillermo Pita
    • Anna González-Neira

    Epidemiology 14 September 2017 Pages: 249 - 256

    

25. Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective

    • Nava Siegelmann-Danieli
    • Itzhak Katzir
    • Yossef Lomnicky

    Epidemiology Open access 14 September 2017 Pages: 257 - 262

    

26. The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy

    • Vasily Giannakeas
    • Steven A. Narod

    Epidemiology 15 September 2017 Pages: 263 - 267

    

27. Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 testing

    • David C. Lin
    • Jonathan R. Genzen

    Epidemiology 19 September 2017 Pages: 269 - 276

    

28. Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population

    • Ying L. Liu
    • Anurag Saraf
    • Kevin Kalinsky

    Epidemiology 25 September 2017 Pages: 277 - 288

    

29. Multidimensional phenotyping of breast cancer cell lines to guide preclinical research

    • Jodi M. Saunus
    • Chanel E. Smart
    • Sunil R. Lakhani

    Brief Report Open access 09 September 2017 Pages: 289 - 301

    

30. Predictive role of loco-regional radiotherapy among metastatic breast cancer patients who had undergone primary tumor surgery

    • Kadri Altundag

    Letter to the Editor 05 September 2017 Pages: 303 - 303

31. A frameshift mutation in BRCA1 leads to hereditary breast and ovarian cancer in one part of a family and to familial pancreatic cancer in another

    • Laura Gieldon
    • Johannes Wagner
    • Andreas Rump

    Letter to the Editor 12 September 2017 Pages: 305 - 307

    

32. 1st UK Interdisciplinary Breast Cancer Symposium—15th–16th January 2018

    Abstracts 10 January 2018 Pages: 309 - 405

33. Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients

    • Carlo Palmieri
    • Rob C. Stein
    • On behalf of the IRIStrial participants

    Correction 25 October 2017 Pages: 407 - 407